• Aquestive Therapeutics will present research on investigational Anaphylm sublingual film at the ACAAI annual meeting, November 12-16, 2026, in Phoenix.
• November 14 oral presentations will examine the drug’s absorption and effects during allergic reactions, including use on top of the tongue.
• November 13 posters will address epinephrine film’s effects at low exposure levels and healthcare providers’ perspectives on anaphylaxis treatment needs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aquestive Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611050700PRIMZONEFULLFEED9870622) on November 05, 2026, and is solely responsible for the information contained therein.